Acute neck pain
Conditions
Brief summary
Group 1) CSMT 2) CSMT sham manipulation 3) Ibuprofen medication 4) Placebo medication. The primary end-point will be defined as the mean pain intensity on a NRS 0-10. The primary analysis will assess the difference in mean pain intensity change from baseline to day 14 after baseline between group 1 and group 2, group 1 and group 3, and group 1 and group 4.
Detailed description
Group 1) CSMT 2) CSMT sham manipulation 3) Ibuprofen medication 4) Placebo medication. 1. Mean pain intensity (NRS 0-10) change from baseline to day 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 in the treatment period, and from baseline to day 7, 28, 56, 84 and 168 post-treatment, respectively, and comparison between group 1 and group 2, group 1 and group 3, group 1 and group 4, and group 3 and 4. 2. Mean duration (hours) of neck pain change from baseline to day etc. See protocol for further details
Interventions
DRUGLACTOSE
DRUGIbuprofen Orifarm 600 mg filmdragerade tabletter
Sponsors
Akershus University Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Group 1) CSMT 2) CSMT sham manipulation 3) Ibuprofen medication 4) Placebo medication. The primary end-point will be defined as the mean pain intensity on a NRS 0-10. The primary analysis will assess the difference in mean pain intensity change from baseline to day 14 after baseline between group 1 and group 2, group 1 and group 3, and group 1 and group 4. | — |
Secondary
| Measure | Time frame |
|---|---|
| Group 1) CSMT 2) CSMT sham manipulation 3) Ibuprofen medication 4) Placebo medication. 1. Mean pain intensity (NRS 0-10) change from baseline to day 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 in the treatment period, and from baseline to day 7, 28, 56, 84 and 168 post-treatment, respectively, and comparison between group 1 and group 2, group 1 and group 3, group 1 and group 4, and group 3 and 4. 2. Mean duration (hours) of neck pain change from baseline to day etc. See protocol for further details | — |
Countries
Norway
Outcome results
None listed